You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Adam covers proteomics and life science mass spectrometry for GenomeWeb.
The study is enrolling up to 2,000 patients at 10 US medical centers and using omics approaches to profile their immune response over the course of a year.
The company is planning a fall launch aimed at the immuno-oncology market but has begun offering early access for SARS-CoV-2 research in the meantime.
The work suggests mass spec can more accurately assess levels of immunotherapy targets like PD-L1 than conventional clinical approaches.
While there were a few new mass spectrometry instrument introductions, vendors focused primarily on software and sample separation advances.
Researchers used a high-throughput proteomic platform to find patterns of protein expression that could identify patients at risk of developing severe infections.
According to the company, the NGS approach will allow it to lower assay costs while increasing its throughput and multiplexing capabilities.
The approach is essentially a simplified version of the technology in Fluidigm's CyTOF instruments, using metal-linked antibodies to measure proteins.
The firm is one of several groups taking a machine learning approach, which it said will enable lower-cost, faster, and more complete proteomic analyses.
A professor of pathology and laboratory medicine, Gregory Tsongalis has published a paper detailing his lab's work on SARS-CoV-2 testing and the challenges faced.
The company uses a combination of transcriptomic and proteomic data combined with machine-learning analysis to identify immune profiles linked to disease.
Researchers have developed a robotic lab assistant, the Verge reports.
CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.
The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.
In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.